Literature DB >> 4074382

Molecular defect in processing alpha-fucosidase in fucosidosis.

K Johnson, G Dawson.   

Abstract

In normal human skin fibroblasts, an enzymatically active 53,000-dalton form of alpha-fucosidase is processed to a 50,000-dalton mature form. Endoglycosidase-H treatment of [35S]methionine pulse-chase labelled material immunoprecipated with a polyclonal antibody to alpha-L-fucosidase (Andrews-Smith & Alhadeff, Biochim. Biophys. Acta 715: 90-96 (1982)) indicated the removal of a single N-linked oligosaccharide unit from both precursor and mature form of alpha-L-fucosidase. Tunicamycin pretreatment of normal fibroblasts indicated that no other N-linked oligosaccharide units were present. Studies on fibroblasts from patients with less than 5% of normal alpha-L-fucosidase activity (fucosidosis) showed 8 of 11 patients synthesized no detectable alpha-fucosidase protein whereas 2 synthesized normal amounts of 53,000 dalton precursor, none of the mature 50,000 dalton form was detectable and one contained small amounts of cross-reacting material. This is the first evidence for processing of alpha-L-fucosidase in cells and the first precise evidence of a molecular defect in fucosidosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4074382     DOI: 10.1016/0006-291x(85)91845-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  alpha-L-fucosidase in human fibroblasts. I. The enzyme activity polymorphism.

Authors:  J G Wauters; K L Stuer; A Van Elsen; P J Willems
Journal:  Biochem Genet       Date:  1992-04       Impact factor: 1.890

Review 2.  The early and late processing of lysosomal enzymes: proteolysis and compartmentation.

Authors:  A Hasilik
Journal:  Experientia       Date:  1992-02-15

3.  Identification of a mutation in the structural alpha-L-fucosidase gene in fucosidosis.

Authors:  P J Willems; J K Darby; R A DiCioccio; P Nakashima; C Eng; K A Kretz; L L Cavalli-Sforza; E M Shooter; J S O'Brien
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

4.  Sequencing and expression of a full-length cDNA for human alpha-L-fucosidase.

Authors:  H Fukushima; J Nishimoto; S Okada
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

5.  Canine alpha-L-fucosidase in relation to the enzymic defect and storage products in canine fucosidosis.

Authors:  C Barker; A Dell; M Rogers; J A Alhadeff; B Winchester
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

Review 6.  Disorders of glycoprotein degradation.

Authors:  M Cantz; B Ulrich-Bott
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

7.  Abnormal expression of alpha-L-fucosidase in lymphoid cell lines of fucosidosis patients.

Authors:  R A DiCioccio; J K Darby; P J Willems
Journal:  Biochem Genet       Date:  1989-06       Impact factor: 1.890

8.  Heterogeneity of mRNA expression in Italian fucosidosis patients.

Authors:  S Guazzi; P Persici; R Gatti; P Durand; J S O'Brien; G Romeo
Journal:  Hum Genet       Date:  1989-04       Impact factor: 4.132

9.  Biosynthesis, processing, and extracellular release of alpha-L-fucosidase in lymphoid cell lines of different genetic origins.

Authors:  R A DiCioccio; K S Brown
Journal:  Biochem Genet       Date:  1988-06       Impact factor: 1.890

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.